wrans/answers2025-10-30 conversation_132
Source: hansard.parliament.uk (2025-10-30)

UK Parliament Hansard data: wrans/answers2025-10-30 conversation_132

Darren Paffey:To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the eligibility criteria for the shingles vaccine, and what steps his Department is taking to ensure that the criteria are clearly communicated to (a) patients and (b) general practices. \p Ashley Dalton: From September 2023, the routine shingles vaccination programme changed from the Zostavax vaccine to the two-dose Shingrix vaccine, to better protect individuals from the effects of shingles, provide better clinical outcomes, and reduce pressures on the health system. The programme was also expanded, and as a result, almost one million more people became eligible for the shingles vaccination.

The expansion is being rolled out in phases to maximise cost-effectiveness and population benefit, ensure consistent messaging to maximise coverage, and take account of National Health Service capacity, all while being consistent with the approach taken by all four nations in the United Kingdom. During the first phase, which commenced in September 2023, those who reach the ages of 65 or 70 years old will be called in for vaccination on or after their 65th or 70th birthday. During the second phase, from September 2028, individuals will be called in for vaccination on or after their 60th or 65th birthday. From 1 September 2033 onwards, vaccination will be routinely offered to those turning 60 years of age on or after their 60th birthday.

Separately, in November 2024, the Joint Committee on Vaccination and Immunisation provided advice on eligibility for the shingles vaccination programme for adults aged 80 years old and over. The Department is considering this advice as it sets the policy on who should be offered shingles vaccinations.

In addition, as of September 2025, all severely immunosuppressed individuals aged 18 years old and over are now eligible for the shingles vaccine in order to protect those who are most at risk of serious illness and complications from shingles.

The UK Health Security Agency (UKHSA) ensures commissioners, providers, and relevant healthcare professionals have access to the necessary resources to communicate accurate information on eligibility for all national vaccination programmes. For example, comprehensive guidance on shingles vaccination is provided for healthcare professionals on GOV.UK website, at the following link:

https://www.gov.uk/government/publications/shingles-vaccination-guidance-for-healthcare-professionals/shingles-immunisation-programme-information-for-healthcare-practitioners

Additionally, to strengthen awareness of the programme amongst health professionals and the wider public, the UKHSA provides a comprehensive suite of public facing resources and assets. This includes information leaflets on shingles vaccination in multiple languages and accessible formats, for instance easy read, British Sign Language, and braille, with further information available at the following link:

https://find-public-health-resources.service.gov.uk/filter?diseases=Shingles&diseases=Varicella&vaccinations=Shingles+vaccine

This is a relatively newly expanded programme, and anyone unsure if they are eligible for the shingles vaccination should check online, on the NHS.UK website, or should speak to their general practice.